濟生一號注射液

국가: 대만

언어: 중국어

출처: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Download 환자 정보 전단 (PIL)
03-03-2021
Download 공공 평가 보고서 (PAR)
27-03-2020

유효 성분:

SODIUM CHLORIDE;;POTASSIUM ACETATE;;SODIUM ACETATE TRIHYDRATE (EQ TO SODIUM ACETATE 3H2O );;MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O);;POTASSIUM PHOSPHATE MONOBASIC(EQ TO POTASSIUM BIPHOSPHATE)(EQ TO POTASSIUM DIHYDROGEN PHOSPHATE);;GLUCOSE MONOHYDRATE

제공처:

濟生醫藥生技股份有限公司 新竹縣湖口鄉勝利村實踐路3號 (47154259)

ATC 코드:

B05BB02

약제 형태:

注射劑

구성:

POTASSIUM ACETATE (4008000100) MG; SODIUM ACETATE TRIHYDRATE (EQ TO SODIUM ACETATE 3H2O ) (4008000670) equivalent to Sodium acetate 0.66mgMG; MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O) (4012001550) equivalent to Magnesium Chloride0.30 mgMG; SODIUM CHLORIDE (4012002100) MG; GLUCOSE MONOHYDRATE (4020000760) equivalent to Glucose 38.00mgMG; POTASSIUM PHOSPHATE MONOBASIC(EQ TO POTASSIUM BIPHOSPHATE)(EQ TO POTASSIUM DIHYDROGEN PHOSPHATE) (5612001910) MG

패키지 단위:

塑膠軟袋裝;;塑膠瓶裝

수업:

製 劑

처방전 유형:

限由醫師使用

Manufactured by:

濟生醫藥生技股份有限公司 新竹縣湖口鄉勝利村實踐路3號 TW

치료 영역:

electrolytes with carbohydrates

치료 징후:

水份、電解質、養份補充、新生兒維持液。

제품 요약:

有效日期: 2027/08/10; 英文品名: CHI SHENG NO.1 Injection

승인 날짜:

2007-08-10